Seeing Is Believing
Currently out of the existing stock ratings of Craig Bijou, 60 are a BUY (58.82%), 27 are a HOLD (26.47%), 15 are a SELL (14.71%).
Analyst Craig Bijou, currently employed at BAML, carries an average stock price target met ratio of 72.22% that have a potential upside of 22.88% achieved within 253 days.
Craig Bijou’s has documented 211 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on AXGN, Axogen at 12-Oct-2026.
Analyst best performing recommendations are on RMED (RA MEDICAL SYSTEMS).
The best stock recommendation documented was for RMED (RA MEDICAL SYSTEMS) at 8/13/2019. The price target of $2500 was fulfilled within 7 days with a profit of $987.5 (65.29%) receiving and performance score of 93.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Jan-2026
$485
$32.71 (7.23%)
$485
7 days ago
(21-Oct-2026)
0/4 (0%)
$56.88 (13.29%)
Buy Since 16-Oct-2023
$503
$50.71 (11.21%)
$454
7 days ago
(21-Oct-2026)
4/10 (40%)
$74.88 (17.49%)
66
Buy Since 18-Jul-2023
$550
$97.71 (21.60%)
$500
7 days ago
(21-Oct-2026)
10/16 (62.5%)
$121.88 (28.47%)
127
Buy Since 24-May-2017
$486
$33.71 (7.45%)
$487
7 days ago
(21-Oct-2026)
28/34 (82.35%)
$57.88 (13.52%)
155
Buy Since 11-Oct-2024
$475
$22.71 (5.02%)
$450
7 days ago
(21-Oct-2026)
2/5 (40%)
$46.88 (10.95%)
97
Which stock is Craig Bijou most bullish on?
Which stock is Craig Bijou most reserved on?
What Year was the first public recommendation made by Craig Bijou?